Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7952667
Reference Type
Journal Article
Title
Stereoselective high-performance liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma
Author(s)
Geisslinger, G; Menzel-Soglowek, S; Kamp, HD; Brune, K
Year
1991
Is Peer Reviewed?
1
Journal
Journal of Chromatography
ISSN:
0021-9673
Volume
568
Issue
1
Page Numbers
165-176
Language
English
PMID
1770094
DOI
10.1016/0378-4347(91)80350-l
Web of Science Id
WOS:A1991FZ16400016
Abstract
An enantioselective high-performance liquid chromatographic assay for the quantitation of the enantiomers of ketamine and its major metabolite norketamine in human plasma is described (assay I). The procedure involved extraction of the compounds from alkalized plasma into cyclohexane. Stereoselective separation was achieved with a prepacked alpha 1-acid glycoprotein column without any derivatization procedure. A second assay using a conventional reversed-phase column to determine total (racemic) ketamine and norketamine is also described. Because of interfering plasma peaks (assay II) the cyclohexane solution was reextracted into 1 M hydrochloric acid. The detection wavelength was 215 nm for all substances. The limit of quantification of the method was ca. 40 ng/ml in plasma. The assays were sensitive and reproducible. The method was demonstrated to be sensitive for stereoselective pharmacokinetic studies of ketamine after clinical doses.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity